Status:
ACTIVE_NOT_RECRUITING
Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT
Lead Sponsor:
BehaVR LLC
Collaborating Sponsors:
University of Utah
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to examine the usefulness of a virtual reality-delivered intervention for individuals with opioid use disorder who are taking medication. The main question it aims t...
Detailed Description
This project is a Phase II, two-arm, parallel randomized controlled trial (RCT) of a virtual reality form of Mindfulness-Oriented Recovery Enhancement (MORE-VR) versus treatment as usual (TAU) for pat...
Eligibility Criteria
Inclusion
- 18 years of age or older
- current DSM-5 OUD diagnosis
- prescribed medications for opioid use disorder (e.g., buprenorphine, methadone)
Exclusion
- completion of a standardized mindfulness intervention (e.g., MORE, MBRP, MBSR)
- active psychosis or suicidality
- reports, or is noted by clinical or study staff as showing cognitive impairment
- condition which might be contraindicated for VR use including seizure disorder, vertigo, severe motion sickness, recent concussion
Key Trial Info
Start Date :
September 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT06021431
Start Date
September 7 2023
End Date
September 1 2025
Last Update
July 2 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Diego
La Jolla, California, United States, 92093
2
University of Utah
Salt Lake City, Utah, United States, 84112